Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adial Pharmaceuticals ( (ADIL) ) just unveiled an update.
Adial Pharmaceuticals has appointed Vinay Shah as their new Chief Financial Officer, effective November 16, 2024, following the resignation of Joseph Truluck. Shah, with over 25 years of experience in the pharmaceutical sector, brings expertise in financial strategy and investor relations. He previously held key roles at Virpax Pharmaceuticals and Aravive, contributing to significant fundraising and strategic initiatives. This leadership change is part of Adial’s broader efforts to advance its strategic goals and enhance shareholder value.
See more insights into ADIL stock on TipRanks’ Stock Analysis page.